Skip to main content

What the FDA labels say about taking them together

Atogepant and topiramate

Atogepant's FDA label of September 30, 2025 names topiramate in its drug interactions section; the topiramate labels PlainMeds reads (4) do not name atogepant. The atogepant label: “Coadministration of QULIPTA with steady-state topiramate, a weak CYP3A4 inducer, resulted in decreased exposure of atogepant in healthy subjects.”

Check it at the source: the atogepant FDA label on DailyMed (effective September 30, 2025, AbbVie Inc.); the topiramate FDA label on DailyMed (effective June 1, 2026, Sun Pharmaceutical Industries, Inc.).

What does the atogepant label say about topiramate?

Atogepant label, drug interactions

Coadministration of QULIPTA with steady-state topiramate, a weak CYP3A4 inducer, resulted in decreased exposure of atogepant in healthy subjects [see Clinical Phar macology ( 12.3 )].

Source: FDA drug label (Qulipta), AbbVie Inc., effective September 30, 2025 (SPL set 8c8ab8f4-32bd-497a-befa-70c8a51d8d52), via openFDA; the full label on DailyMed

What does the topiramate label say about atogepant?

Topiramate's label (effective June 1, 2026) and its 3 other brand-application labels do not name atogepant in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Topiramate), Sun Pharmaceutical Industries, Inc., effective June 1, 2026 (SPL set 3c909a53-ae66-4b28-a741-b60bb25a69cf), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

0Atogepant generic labelers
47Topiramate generic labelers
AtogepantTopiramate
Labeled forMigraineSeizures and epilepsy, Migraine
Boxed warningNoNo
Pharmacy cost (NADAC)$38.36 per tablet 10 mg tablet$0.0567 per tablet 100 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?